CNS Open Data
Latest UpdatesOpen DatasetsClinical TrialsResearch GuidesTrend ReportsGlossaryData SourcesAbout
CNS Open Data— Open Science Portal for Central Nervous System Research|Research Guides|Trend Reports|Glossary|Ranking|Open Datasets|About|Privacy Policy
AlzforumOpenNeuroDANDI ArchiveAgora (AMP-AD)
HomePeer-Reviewed PaperALSUntangled Review 62: Systematic Scientific Appraisal of Taurursodiol and Sodium Phenylbutyrate Regimens
ENCALS & ALSUntangledALS & Motor NeuronPeer-Reviewed PaperFAIR Metadata / API

ALSUntangled Review 62: Systematic Scientific Appraisal of Taurursodiol and Sodium Phenylbutyrate Regimens

April 5, 2026
Bedlack R, ALSUntangled Scientific Consortium

Study Design & Technical Specifications

Sample Size / Cohort

Documented in primary study

Subject / Study Model

CNS Experimental / Clinical Model

Analytical Modalities

Systematic ReviewOff-label Therapeutics

Primary Abstract & Repository Description

Source: ENCALS & ALSUntangled
Evidence-based review examining cellular mechanisms, mitochondrial preservation data, clinical trial efficacy claims, and safety profiles for combination chaperone therapies.
CNS Open Data Deep Research Brief

Editorial Critique, Methodological Value & Reusability Guide

Structured via CNS Domain Knowledge Engine

1. Scientific Context & Translational Bottlenecks

This resource from ENCALS & ALSUntangled ("ALSUntangled Review 62: Systematic Scientific Appraisal of Taurursodiol and Sodium Phenylbutyrate Regimens") addresses critical scientific questions within Amyotrophic Lateral Sclerosis (ALS) & Motor Neuron Disease. Research in this domain currently faces major translational bottlenecks, including rapid upper and lower motor neuron degeneration, TDP-43 proteinopathy mislocalization, and high clinical heterogeneity in survival trajectories. By focusing on key thematic elements (ALSUntangled, ALS, TUDCA, Sodium Phenylbutyrate, Systematic Review), this work contributes empirical evidence toward understanding how molecular, cellular, or systems-level alterations relate to core disease pathways such as plasma/CSF Neurofilament Light Chain (NfL), C9orf72/SOD1/FUS genetics, cryptic exon biomarkers, and ALSFRS-R slopes. Integrating these findings into the broader open science ecosystem helps reduce fragmentation across independent laboratories and accelerates hypothesis verification.

日本語解説を表示 (Japanese)

ENCALS & ALSUntangledより公開された本リソース(「ALSUntangled Review 62: Systematic Scientific Appraisal of Taurursodiol and Sodium Phenylbutyrate Regimens」)は、筋萎縮性側索硬化症(ALS)・運動ニューロン疾患領域における重要な学術的・臨床的課題に焦点を当てています。現在の筋萎縮性側索硬化症(ALS)・運動ニューロン疾患研究では、上位・下位運動ニューロンの急速な変性進行、TDP-43プロテイノパチーの局在異常・スプライシング破綻、および生存期間・進行速度の著しい臨床的異質性といったトランスレーショナルリサーチ上のボトルネックが存在します。本リソースは関連キーワード(ALSUntangled, ALS, TUDCA, Sodium Phenylbutyrate, Systematic Review)を軸として、血漿・髄液中ニューロフィラメント軽鎖(NfL)、C9orf72/SOD1/FUS遺伝子変異、クリプティックエクソン指標、およびALSFRS-R変化率などの主要経路や病態メカニズムの理解に資する知見・データを提供しており、研究室や機関ごとに分散しがちな知見をオープンサイエンス基盤上で統合・検証する上で重要な位置づけを持ちます。

2. Methodology & Data Architecture Value

Methodologically, this paper integrates Systematic Review, Off-label Therapeutics within a CNS Experimental / Clinical Model framework (cohort/experimental samples documented in source protocol). Curated via ENCALS & ALSUntangled, the analytical approach provides structured insights into Amyotrophic Lateral Sclerosis (ALS) & Motor Neuron Disease pathophysiology. Evaluating the reported outcomes alongside Systematic Review, Off-label Therapeutics technical specifications allows researchers to benchmark effect sizes, assay sensitivity, and experimental reproducibility against established reference cohorts.

日本語解説を表示 (Japanese)

方法論の観点から、本研究(種別: paper)は神経科学実験・臨床モデル(規模: 原著プロトコルに記載されたコホート・実験サンプル)を対象に「Systematic Review, Off-label Therapeutics」を適用しています。ENCALS & ALSUntangledに収録された本知見は、筋萎縮性側索硬化症(ALS)・運動ニューロン疾患の病態生理や評価指標を精緻に分析する枠組みを提示しています。採用されたモダリティ(Systematic Review, Off-label Therapeutics)の測定仕様と報告された効果量を既存の参照コホートと比較することで、測定感度のベンチマークや実験プロトコルの再現性評価に直接活用できます。

3. Secondary Analysis & Reusability Scenarios

Researchers and computational neuroscientists can reuse this resource across multiple secondary workflows: (1) Cross-Cohort Harmonization & Meta-Analysis — combining these Systematic Review, Off-label Therapeutics records with complementary repositories (such as OpenNeuro, DANDI, Agora, or Europe PMC) to increase statistical power; (2) Computational Benchmarking & Machine Learning — utilizing the documented features (ALSUntangled, ALS, TUDCA, Sodium Phenylbutyrate, Systematic Review) as training, validation, or out-of-distribution test sets for predictive biomarker discovery in Amyotrophic Lateral Sclerosis (ALS) & Motor Neuron Disease; and (3) Experimental Protocol Alignment — referencing the study design (CNS Experimental / Clinical Model, cohort/experimental samples documented in source protocol) to calibrate sample size calculations (power analysis) and endpoint selection for upcoming preclinical or clinical studies.

日本語解説を表示 (Japanese)

本リソースは以下のような二次解析・再利用シナリオに幅広く活用可能です。(1) コホート横断的ハーモナイゼーションとメタ解析:本リソースの「Systematic Review, Off-label Therapeutics」データを他の公開リポジトリ(OpenNeuro、DANDI、Agora、ADNI等)の同種データと統合し、統計的検出力(Statistical Power)を高めた統合解析を実施する。(2) 機械学習・バイオマーカー予測モデルの検証:抽出された特徴量や関連因子(ALSUntangled, ALS, TUDCA, Sodium Phenylbutyrate, Systematic Review)を、筋萎縮性側索硬化症(ALS)・運動ニューロン疾患の進行予測・サブタイプ分類モデルの外部検証(External Validation)や転移学習データとして利用する。(3) 後続研究のプロトコル設計:対象モデル(神経科学実験・臨床モデル)およびサンプル規模(原著プロトコルに記載されたコホート・実験サンプル)の設計仕様を参照し、新規の非臨床試験や臨床研究におけるサンプルサイズ設計(検出力計算)や主要評価項目の妥当性検討に役立てる。

4. Methodological Limitations & Caveats

While curated from an authoritative scientific source, secondary analysts should account for potential cohort selection biases and site-specific batch effects. Specifically, when interpreting Systematic Review, Off-label Therapeutics results in Amyotrophic Lateral Sclerosis (ALS) & Motor Neuron Disease, researchers must control for confounding variables (such as age, sex, post-mortem interval, scanner/instrument drift, or medication state) and verify compliance with open-access attribution requirements (source repository terms).

日本語解説を表示 (Japanese)

信頼性の高い学術情報源から収録されていますが、二次解析や他研究との比較を行う際には、コホート選択バイアスや測定施設間差(バッチエフェクト)に留意する必要があります。特に筋萎縮性側索硬化症(ALS)・運動ニューロン疾患における「Systematic Review, Off-label Therapeutics」データの解釈では、年齢・性別・罹病期間・測定機器のキャリブレーション差・併用薬などの交絡因子を適切に補正することが推奨されます。また、データや図表の二次利用時は提供元(ENCALS & ALSUntangled)の利用条件(open_access)および適切な引用表記を遵守してください。

Data Access, Reproducibility & Analysis Starter Guide

FAIR Open Science & Clinical Metadata Verification Protocol

FAIR Metadata / API

Quick Data Access & Structured Export

Open the primary repository directly or download structured metadata (JSON / CSV) in one click.

Open Primary Data (ENCALS & ALSUntangled)

This resource is indexed under FAIR (Findable, Accessible, Interoperable, and Reusable) open-science metadata standards, enabling programmatic cross-referencing across Europe PMC, Semantic Scholar, ClinicalTrials.gov, and CNS Open Data.

Programmatic Data Retrieval (Python Starter Code & Recommended SDKs)

Python Quickstart: Query Europe PMC & Semantic Scholar Metadata

# Fetch structured bibliographic & open-access data via Europe PMC REST API
import urllib.request
import urllib.parse
import json

query = "ALSUntangled Review 62: Systematic Scientific Appraisal of Taurursodiol and Sodi"
url = f"https://www.ebi.ac.uk/europepmc/webservices/rest/search?query={urllib.parse.quote(query)}&format=json&resultType=core"

with urllib.request.urlopen(url, timeout=10) as response:
    payload = json.loads(response.read().decode("utf-8"))
    results = payload.get("resultList", {}).get("result", [])
    if results:
        record = results[0]
        print("Title:", record.get("title"))
        print("Journal / Source:", record.get("journalTitle") or record.get("bookOrReportDetails"))
        print("Cited By Count:", record.get("citedByCount", 0))

Recommended Open-Source Software & SDKs

NiBabelPython SDK

Read and write access to NIfTI, GIFTI, and BIDS neuroimaging file formats in Python.

Scanpy (scverse)Python / AnnData

Scalable Python toolkit for analyzing AnnData (.h5ad) single-cell gene expression matrices.

Standardized 4-Step Workflow & Governance Checklist

Standardized Acquisition & Preprocessing Workflow

1. Programmatic Metadata & Full-Text OA Retrieval

Query Europe PMC or Crossref REST APIs using the persistent DOI/URL to retrieve structured XML full text, supplementary tables, and grant links.

2. Study Design & Cohort Eligibility Screening

Extract sample size, inclusion/exclusion criteria, and primary outcome endpoints for systematic review (PRISMA) inclusion.

3. Data Availability & Supplementary Repository Linkage

Locate accession numbers (GEO, SRA, OpenNeuro, DANDI, Zenodo, Figshare) referenced in the Data Availability section.

4. Citation Graph & Replication Tracking

Monitor supporting and contrasting citations over time to verify whether key findings have been independently replicated.

Reproducibility & Governance Checklist

  • Verify whether the source is a peer-reviewed journal publication or an unrefereed preprint before clinical citation.
  • Check supplementary data licenses (CC-BY / CC0) when extracting figures or summary statistics for meta-analyses.
  • Cross-reference NCT clinical trial identifiers when evaluating therapeutic efficacy or biomarker endpoints.

Tags & Modalities

Systematic ReviewOff-label Therapeutics#ALSUntangled#ALS#TUDCA#Sodium Phenylbutyrate#Systematic Review

Bibliometrics, Peer-Review Status & Citation Export

Cross-referenced via Semantic Scholar, Europe PMC & bioRxiv

1. Citation Metrics & Context Breakdown

0
Total Citations
0
Influential Citations

Citation Context Breakdown

Citation intent breakdown (Supporting vs. Contrasting) is currently accumulating in Semantic Scholar for this record. Researchers reusing this resource should cite the primary DOI/URL using the standardized formats below.

2. Peer-Review Validation & Revision History

Verified Publication / Open Dataset Record

Metadata and license integrity verified against primary repository records.

3. Standardized Academic Citation & BibTeX Export

Selected Format (APA)
Bedlack R & ALSUntangled Scientific Consortium (2026). ALSUntangled Review 62: Systematic Scientific Appraisal of Taurursodiol and Sodium Phenylbutyrate Regimens. ENCALS & ALSUntangled. https://www.encals.eu/
BibTeX Entry (LaTeX / Reference Managers)
@article{r2026alsu,
  title = {ALSUntangled Review 62: Systematic Scientific Appraisal of Taurursodiol and Sodium Phenylbutyrate Regimens},
  author = {Bedlack R and ALSUntangled Scientific Consortium},
  year = {2026},
  journal = {ENCALS & ALSUntangled},
  howpublished = {\url{https://www.encals.eu/}},
  doi = {},
  note = {CNS Open Data: als}
}

Related ALS & Motor Neuron Research & Datasets

Explore All Datasets
PreprintbioRxiv (Neuroscience)

Spontaneous slow waves index multiple dimensions of recovery in Disorders of Consciousness

Whether and how residual awareness is expressed in patients with Disorders of Consciousness (DoC) depends on the severity of brain damage and the transient functional state of the cortex at assessment. Classically, DoC are associated with electroencephalographic (EEG) slowing, marked by high-amplitu...

10/8/2026Read Analysis
PreprintbioRxiv (Neuroscience)

Immediate cortical responses to transcranial magnetic stimulation of the human motor leg area

Background: Immediate transcranial evoked potentials (iTEPs) are ultra-early electroencephalographic responses elicited by single-pulse transcranial magnetic stimulation (TMS) of the primary motor cortical hand area (M1-HAND). Their characteristic latency, waveform, and sensitivity to short-interval...

10/8/2026Read Analysis
PreprintmedRxiv (Neurology)

Not All Entropy Is Equal: Why Representation Matters for Biological Interpretation in Dementia EEG

ObjectiveTo examine what a dementia-associated electroencephalography (EEG) entropy difference permits us to infer about brain dynamics by testing its dependence on permutation-entropy (PE) representation. MethodsFour PE settings represented identical alpha-band data from 1,177 CAUEEG recordings. N...

9/29/2026Read Analysis
PreprintmedRxiv (Neurology)

Assessing respiratory rates and signs of air hunger using the PneumoRator sensor.

ObjectivesTo investigate whether the PneumoRator wearable sensor could accurately assess Respiratory Rate (RR) and signs of air hunger (SAH) compared with clinician-observed assessment in adults with and without breathing pattern disorder (BrPD). DesignA pilot cross-sectional observational study. ...

9/26/2026Read Analysis
PreprintbioRxiv (Neuroscience)

KCNQ2/3 Regulates Efferent Mediated Slow Excitation of Vestibular Afferents in Mammals

Investigating motor neuron excitability in amyotrophic lateral sclerosis (ALS), this research reveals how KCNQ potassium channel subunits regulate efferent-mediated slow excitation. These electrophysiological findings uncover critical protective mechanisms against motor neuron degeneration.

7/28/2026Read Analysis
PreprintbioRxiv (Neuroscience)

Evidence-Gated Plasticity and Context-Dependent Consolidation for Multi-Goal Learning in Spiking Neural Networks

Background / Introduction: Biologically inspired spiking neural networks offer a mechanistic framework for adaptive behavior, yet learning multiple goals remains challenging when synaptic updates for different targets interfere. We investigated whether multi-timescale plasticity and context-specific...

10/10/2026Read Analysis

Related Data & Resources

Open Datasets

Explore Related Datasets

Find neuroimaging or multi-omics datasets relevant to this topic.

Clinical Trials

View Clinical Pipeline

Check investigational drugs, clinical trials, and clinical guidelines.

Academic Research & Medical Information Disclaimer

This page provides structured scientific metadata, methodological critiques, and open-data reusability guidelines intended strictly for neuroscience researchers and data scientists. It does not constitute medical advice, clinical diagnosis, or treatment recommendations.

Was this resource helpful?

Help improve data curation by sharing your feedback.

Open Source